The 4th NextGen Therapies for SJIA and MAS: part 1 the elephant in the room: diagnostic/classification criteria for systemic juvenile idiopathic arthritis and adult-onset still’s disease
Authors' conclusion
The classification session at the NextGen 2022 conference helped to serve this purpose, establishing the need for a revised definitional system that transcends the fault lines that remain in existing definitions.
Study context
- Population
- Patients with sJIA and AOSD (Still's disease)
Main finding
As reported in the abstract
- Existing terms too narrow: Still's population unnecessarily subdivided between pediatric-onset and adult-onset disease, excluding children in whom overt arthritis is delayed or absent
- Classification session at NextGen 2022 established the need for a revised definitional system transcending fault lines of existing definitions
Original publication
The 4th NextGen Therapies for SJIA and MAS: part 1 the elephant in the room: diagnostic/classification criteria for systemic juvenile idiopathic arthritis and adult-onset still’s disease. Pediatr Rheumatol Online J. Published 5 January 2024. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →